MA (EU) number
EU/1/16/1114/001
EU/1/16/1114/002
EU/1/16/1114/003
EU/1/16/1114/004
(Invented) 
name
Bortezomib 
Hospira  
Bortezomib 
Hospira  
Bortezomib 
Hospira  
Bortezomib 
Hospira  
Strength
Pharmaceutical 
Form
Route of 
Administration
Immediate 
Packaging
Pack size
3.5 mg
2.5 mg
3 mg
1 mg
Powder for solution 
for injection
Powder for solution 
for injection
Powder for solution 
for injection
Powder for solution 
for injection
Intravenous use, 
Subcutaneous use
Intravenous use, 
Subcutaneous use
Intravenous use, 
Subcutaneous use
Intravenous use, 
Subcutaneous use
vial (glass)
vial (glass)
vial (glass)
vial (glass)
1 vial
1 vial
1 vial
1 vial
1/1
